Machine learning models predict lymph node metastasis in patients with stage T1-T2 esophageal squamous cell carcinoma
Dong-Lin Li1, Lin Zhang2, Hao-Ji Yan3,4
1Department of Thoracic Surgery, Suining Central Hospital, Sunning, China.
Frontiers in Oncology
|September 26, 2022
Summary
Machine learning models accurately predict lymph node metastasis in early-stage esophageal squamous cell carcinoma. The best model, using naive Bayes, outperformed traditional T stage prediction.
Area of Science:
- Oncology
- Medical Informatics
- Machine Learning
Background:
- Accurate prediction of lymph node metastasis (LNM) is crucial for stage T1-T2 esophageal squamous cell carcinoma (ESCC).
- Existing methods for LNM prediction in early-stage ESCC present challenges.
Purpose of the Study:
- To evaluate the performance of machine learning (ML) models in predicting LNM for patients with stage T1-T2 ESCC.
- To identify the optimal ML model for LNM prediction in this patient cohort.
Main Methods:
- A retrospective study included 1097 patients with stage T1-T2 ESCC.
- Thirty-six ML models were developed using various algorithms and feature selection techniques.
- Model performance was assessed using the area under the receiver operating characteristic curve (AUC) on training and external test sets.
Main Results:
- ML models demonstrated good predictive performance, with a median bootstrapped AUC of 0.659.
- The optimal model, a naive Bayes algorithm with determination coefficient feature selection, achieved an AUC of 0.715 in the training set.
- This optimal ML model showed superior performance in the external test set with an AUC of 0.752, outperforming T stage prediction (AUC 0.624).
Conclusions:
- Machine learning models offer significant value in predicting LNM for stage T1-T2 ESCC.
- The naive Bayes algorithm, combined with determination coefficient feature selection, emerged as the best-performing model for LNM prediction.


